Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

NCT02560610 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Eosinophilic Asthma

Interventions

DRUG: OC000459
DRUG: Placebo

Sponsor

Chiesi Farmaceutici S.p.A.

Collaborators

[object Object]